Who owns Arena Pharmaceuticals?

Top Holders and Investors of ARNA Stock

Find out what company owns Arena Pharmaceuticals, who bought ARNA this quarter, and who sold shares of ARNA stock?

Fund or Company Name Number of Shares Valued At As Of
BlackRock Fund Advisors 11.23M $15.94M Dec 2016
BlackRock Institutional Trust Company, N.A. 6.24M $8.86M Dec 2016
BlackRock Investment Management 950129 $1.35M Dec 2016
Morgan Stanley 544618 $795142 Mar 2017
Two Sigma Investments 312833 $456736 Mar 2017
BlackRock Advisors 252054 $357916 Dec 2016
BlackRock 220748 $313462 Dec 2016
Two Sigma Advisers 42100 $61045 Mar 2017
Quantitative Investment Management 17000 $432990 Sep 2017
Janus Capital Management 16247 $24045 Mar 2017
BlackRock Japan 14716 $21043 Dec 2016
Metlife Securities 1800 $3006 Dec 2016

Who sold Arena Pharmaceuticals?

Fund Name Date Sold Shares Held Valued At
Bank of New York Mellon March 31, 2017 1.18M $1.73M
Nationwide Fund Advisors March 31, 2017 430708 $628833
Camber Capital Management June 30, 2017 425000 $7.17M
Credit Suisse AG March 31, 2017 395948 $0
Technical Financial Services March 31, 2017 340092 $496534
Rhumbline Advisers March 31, 2017 286957 $418957
New York State Common Retirement Fund March 31, 2017 220801 $322369
KCG Holdings March 31, 2017 194032 $283286
Wells Fargo & Company March 31, 2017 177515 $259171
American International March 31, 2017 150966 $220410
T. Rowe Price Associates March 31, 2017 147300 $215058
Bank of America Corporation March 31, 2017 96379 $140713
Legal & General March 31, 2017 59138 $85750
Two Sigma Securities Dec. 31, 2016 35160 $49927
Advisor March 31, 2017 33317 $47976
BlackRock Dec. 31, 2016 19866 $28408
Teacher Retirement System Of Texas March 31, 2017 19678 $28926
Great-West Life Assurance Company March 31, 2017 19241 $28091
Royal Bank of Canada Dec. 31, 2016 18096 $26239
Cedar Capital March 31, 2017 16500 $23925
Jpmorgan Chase & Co March 31, 2017 1859 $2992